Simplex Trading’s Biohaven BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$266K Sell
17,900
-8,900
-33% -$95.8K ﹤0.01% 4362
2026
Q1
$227K Sell
26,800
-170,300
-86% -$1.86M ﹤0.01% 4159
2025
Q4
$2.23M Buy
197,100
+88,200
+81% +$1.09M ﹤0.01% 1893
2025
Q3
$1.63M Buy
108,900
+80,700
+286% +$1.17M ﹤0.01% 2524
2025
Q2
$397K Buy
28,200
+15,100
+115% +$269K ﹤0.01% 3760
2025
Q1
$314K Sell
13,100
-12,300
-48% -$434K ﹤0.01% 3884
2024
Q4
$948K Sell
25,400
-13,200
-34% -$616K ﹤0.01% 2896
2024
Q3
$1.93M Buy
38,600
+26,600
+222% +$1.03M ﹤0.01% 2309
2024
Q2
$416K Buy
12,000
+11,100
+1,233% +$439K ﹤0.01% 3844
2024
Q1
$49K Sell
900
-2,300
-72% -$114K ﹤0.01% 6266
2023
Q4
$136K Sell
3,200
-50,200
-94% -$1.56M ﹤0.01% 5066
2023
Q3
$1.39M Sell
53,400
-13,200
-20% -$274K ﹤0.01% 2372
2023
Q2
$1.59M Sell
66,600
-66,100
-50% -$1.14M ﹤0.01% 2167
2023
Q1
$1.81M Sell
132,700
-43,500
-25% -$692K ﹤0.01% 2028
2022
Q4
$2.44M Buy
+176,200
New +$2.49M ﹤0.01% 1714

Other funds holding BHVN

Simplex Trading's BHVN Position: Q2 2026 in Review

Simplex Trading reduced its Biohaven (BHVN) stake by 33% in Q2 2026, selling an estimated $125K and leaving 23,317 shares worth $347K. The position accounts for ﹤0.01% of the portfolio, ranked #4054.

Simplex Trading first reported a position in BHVN in Q4 2022 and has held it in 11 quarters since. The position peaked at $920K in Q3 2025. 296 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.

  • Simplex Trading held 23,317 shares of Biohaven worth $347K as of Q2 2026.
  • Simplex Trading sold 11,620 Biohaven shares in Q2 2026, an estimated $125K.
  • Biohaven made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #4054 holding.
  • Simplex Trading first reported a position in Biohaven in Q4 2022 and has held it in 11 quarters since.
  • Simplex Trading's Biohaven position peaked at $920K in Q3 2025.
  • 296 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.